DNA Damage Response - A Basic Explanation

Why It Matters

Targeting DNA repair defects could deliver more effective, less toxic therapies for aggressive brain tumors, accelerating precision oncology.

Key Takeaways

• Conventional brain tumor therapies rely on cytotoxic chemotherapy and radiation.
• Tumor cells activate DNA damage response pathways to repair therapy‑induced lesions.
• Specific mutations impair DNA repair mechanisms within certain brain tumors.
• IDH mutations disrupt metabolism and block DNA repair pathways.
• Exploiting DNA repair defects offers a novel therapeutic strategy.

Summary

Conventional treatment of adult and pediatric brain tumors relies heavily on cytotoxic chemotherapy and radiation, both of which induce extensive DNA damage in cancer cells.

The video explains that tumor cells often survive this assault by activating DNA damage response (DDR) pathways that repair the lesions, allowing continued proliferation. Researchers have identified mutations in these tumors that compromise DNA repair, notably IDH mutations that alter cellular metabolism and directly inhibit repair mechanisms.

These findings were described as “unexpected” but point to a new therapeutic angle: exploiting inherent DNA repair deficiencies to selectively kill tumor cells while sparing normal tissue.

If drugs can be designed to further block the already weakened DDR in IDH‑mutant tumors, clinicians may achieve higher efficacy with reduced systemic toxicity, reshaping the management of hard‑to‑treat brain cancers.

Original Description

For more information on tumors or #YaleMedicine, visit: https://www.yalemedicine.org/departments/pediatric-hematology-and-oncology-program.

#yaleschoolofmedicine #yalemedicine #medicineexplained #scienceexplained